AusBiotech congratulates its members that are amongst recipients of the third round of the $18.8 million funding from the BioMedTech Horizons (BMTH) program, an initiative of the Medical Research Future Fund (MRFF).
The program targets innovative solutions to address unmet clinical needs in key focus areas.
As digital evolution continues to drive change across many aspects of healthcare, the third funding round targeted support for SMEs and companies researching digitally-enabled medical devices in mobile health, health information technology, wearable devices, telehealth and telemedicine, and digitally-enabled personalised medicine.
- Anisop Holdings, New South Wales: developing a nano-optimised surface to prevent orthopaedic and dental implant infections.
- Bionic Vision Technologies, Victoria: developing an implantable vision system and algorithm in their Bionic Eye Generation three device to restore functional vision for blind patients.
- Hemideina, Victoria: developing a miniature, low-energy wireless power and data transmission system for implantable medical devices.
- OncoRes Medical, Western Australia: developing compact wireless technology for improvement in the accuracy during breast-conserving surgery.
- All other recipients of the BMTH funding.
The funding, announced by health minister Greg Hunt, is available for SMEs to develop new health, biological and medical technologies to reach proof-of-concept so they are attractive for private capital investment and commercialisation.
The Australian Government's $45 million BioMedTech Horizons program is an initiative to support innovative collaborative health technologies and drive discoveries towards proof-of-concept and commercialisation that address key health challenges, as well as to maximise entrepreneurship and idea potential.